Open AccessBreast implant-associated anaplastic large-cell lymphoma: A case report and a review of literature
Author(s) -
Н Г Чернова,
Н Г Чернова,
Е Е Звонков,
Е Е Звонков,
А М Kovrigina,
А М Ковригина,
Andrey Sudarikov,
Andrey Sudarikov,
Д С Бадмажапова,
Д С Бадмажапова,
Nelly G. Gabeeva,
Nelly G. Gabeeva,
Tatiana Obukhova,
Tatiana Obukhova,
S R Karagyulyan,
С. Р. Карагюлян,
Savchenko Vg,
В. Г. Савченко
Publication year - 2017
Publication title -
terapevtičeskij arhiv
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.181
H-Index - 14
eISSN - 2309-5342
pISSN - 0040-3660
DOI - 10.17116/terarkh201789793-98
Subject(s) - medicine , anaplastic large cell lymphoma , breast implant , lymphoma , implant , large cell , oncology , dermatology , surgery , adenocarcinoma , cancer
Breast implant-associated anaplastic large-cell lymphoma will be identified as a separate nosological entity in the 2017 adapted WHO classification due to differences in its clinical presentations, pathogenesis, and prognosis with those of nodal and cutaneous anaplastic large-cell lymphomas. The paper gives a review of the literature and describes the authors’ own clinical case of common breast implant-associated anaplastic large-cell lymphoma involving breast tissue, axillary lymph nodes, anterior chest muscles, and bone marrow. The treatment policy chosen by the authors could achieve complete remission.